Cancer Analysis

Related Publications

Parikh N, Hilsenbeck S, Creighton CJ, Dayaram T, Shuck R, Shinbrot E, et al.. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. J Pathol. 2014 ;232(5):522-33.

Arai E, Sakamoto H, Ichikawa H, Totsuka H, Chiku S, Gotoh M, et al.. Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome. Int J Cancer. 2014 ;135(6):1330-42.

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, et al.. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014 ;16(10):1333-40.

Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, et al.. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014 ;20(14):3842-8.

Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al.. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 ;26(3):319-330.

Shinbrot E, Henninger EE, Weinhold N, Covington KR, A Göksenin Y, Schultz N, et al.. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 2014 ;24(11):1740-50.

Yu Z, Kim J, He L, Creighton CJ, Gunaratne PH, Hawkins SM, et al.. Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer. Biol Reprod. 2014 ;91(5):113.

Pickering CR, Zhou JH, J Lee J, Drummond JA, S Peng A, Saade RE, et al.. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 ;20(24):6582-92.

Parfenov M, Pedamallu CSekhar, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, et al.. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 ;111(43):15544-9.

Scollon S, Bergstrom K, Kerstein RA, Wang T, Hilsenbeck SG, Ramamurthy U, et al.. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med. 2014 ;6(9):69.